SK281130B6 - Topická farmaceutická formuácia - Google Patents

Topická farmaceutická formuácia Download PDF

Info

Publication number
SK281130B6
SK281130B6 SK1532-92A SK153292A SK281130B6 SK 281130 B6 SK281130 B6 SK 281130B6 SK 153292 A SK153292 A SK 153292A SK 281130 B6 SK281130 B6 SK 281130B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
topical pharmaceutical
polymeric film
pharmaceutical formulation
Prior art date
Application number
SK1532-92A
Other languages
English (en)
Slovak (sk)
Inventor
Friedrich Richter
Marianne Roser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919111210A external-priority patent/GB9111210D0/en
Priority claimed from GB929204472A external-priority patent/GB9204472D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK281130B6 publication Critical patent/SK281130B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1532-92A 1991-05-23 1992-05-21 Topická farmaceutická formuácia SK281130B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919111210A GB9111210D0 (en) 1991-05-23 1991-05-23 Pharmaceutical composition
GB929204472A GB9204472D0 (en) 1992-03-02 1992-03-02 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
SK281130B6 true SK281130B6 (sk) 2000-12-11

Family

ID=26298942

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1532-92A SK281130B6 (sk) 1991-05-23 1992-05-21 Topická farmaceutická formuácia

Country Status (31)

Country Link
US (3) US5866105A (fr)
EP (1) EP0515312B1 (fr)
JP (1) JP3527749B2 (fr)
KR (1) KR100367150B1 (fr)
AT (1) AT400518B (fr)
AU (1) AU642090B2 (fr)
CA (1) CA2069153C (fr)
CH (1) CH683237A5 (fr)
CY (1) CY2070B1 (fr)
CZ (1) CZ284232B6 (fr)
DE (1) DE4215677B4 (fr)
DK (1) DK0515312T3 (fr)
ES (1) ES2091441T3 (fr)
FI (1) FI109333B (fr)
FR (1) FR2676647B1 (fr)
GB (1) GB2256138B (fr)
GR (1) GR3021551T3 (fr)
HK (1) HK1000242A1 (fr)
HU (1) HU219480B (fr)
IE (1) IE66476B1 (fr)
IL (1) IL101944A (fr)
IT (1) IT1254571B (fr)
LU (1) LU88117A1 (fr)
MX (1) MX9202407A (fr)
NO (1) NO300084B1 (fr)
NZ (1) NZ242849A (fr)
PH (1) PH31205A (fr)
RO (1) RO112081B1 (fr)
RU (1) RU2110257C1 (fr)
SK (1) SK281130B6 (fr)
ZA (1) ZA923765B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19643831A1 (de) 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
KR20000064607A (ko) * 1996-03-16 2000-11-06 훽스트 악티엔게젤샤프트 손발톱건선치료용국소제제
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
RO118174B1 (ro) 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6727401B1 (en) 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
NZ506925A (en) * 1998-04-17 2003-03-28 Bertek Pharm Inc Topical formulations for the treatment of nail fungal diseases
WO2000054732A1 (fr) * 1999-03-16 2000-09-21 Mark Yezbick Composition de vernis a ongle
US6403063B1 (en) 1999-07-26 2002-06-11 Kenneth I. Sawyer Method of treating nail fungus
DE19949517A1 (de) * 1999-10-14 2001-04-19 Henkel Kgaa Festigende Haarreinigungsmittel
DE60028415T2 (de) * 1999-12-30 2007-06-06 Acrymed, Portland Methode und zusammensetzungen für verbesserte abgabevorrichtungen
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CN1575165A (zh) * 2001-09-04 2005-02-02 泰姆斯多夫药品有限公司 含有塞托康唑的治疗指甲功能异常紊乱的膏药
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
US6921529B2 (en) * 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
WO2004017903A2 (fr) * 2002-08-20 2004-03-04 Pinnell Doren M Procedes pour traiter des infections fongiques
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
PL2106805T3 (pl) 2003-03-21 2011-10-31 Nexmed Holdings Inc Przeciwgrzybicza powłoka na paznokcie
DE602004028284D1 (de) 2003-12-08 2010-09-02 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
AU2005280443B2 (en) 2004-07-30 2011-02-03 Avent, Inc. Antimicrobial silver compositions
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
CN101010004B (zh) * 2004-07-30 2012-10-03 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
WO2006034249A2 (fr) * 2004-09-20 2006-03-30 Acrymed, Inc. Compositions antimicrobiennes amorphes
FR2878157B1 (fr) * 2004-11-23 2007-03-02 Durlin France Sa Composition de vernis a base de solvant a base de solvant d'origine vegetale
US20060165747A1 (en) * 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
PL1931309T3 (pl) * 2005-09-29 2013-02-28 Novartis Ag Kompozycja przeciwgrzybicza
CN101262848B (zh) * 2005-09-29 2011-05-11 诺瓦提斯公司 抗真菌组合物
US20080299060A1 (en) * 2006-01-02 2008-12-04 Tlt Medical Ltd. Pharmaceutical Composition for the Treatment of Nail Diseases
EP2015722B1 (fr) * 2006-04-28 2016-11-16 Avent, Inc. Pansements pour site antimicrobien
WO2008102349A2 (fr) * 2007-02-21 2008-08-28 Power Paper Ltd Formulation de terbinafine
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
AU2009316270B2 (en) * 2008-11-24 2015-08-27 Avent, Inc. Antimicrobial laminate constructs
WO2010069519A1 (fr) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
US8193232B2 (en) * 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
ES2437395T3 (es) * 2009-03-20 2014-01-10 Stiefel Laboratories, Inc. Composiciones de monoglicéridos de ácidos grasos
IN2014DN11232A (fr) * 2012-07-06 2015-10-02 Leo Pharma As
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2002795B (en) * 1977-07-15 1982-03-17 Mallinckrodt Inc Nail enamel compositions their preparation and use
EP0024587B1 (fr) * 1979-08-22 1984-11-14 Sandoz Ag Propénylamines, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation comme médicaments
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
AU599064B2 (en) * 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
HU200914B (en) * 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
LU86924A1 (fr) * 1987-06-19 1989-03-08 Oreal Vernis a ongles anhydres
US4920109A (en) * 1988-04-18 1990-04-24 Merck & Co., Inc. Antifungal compositions and method of controlling mycotic infections
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
CA2008775C (fr) * 1989-02-24 1998-12-22 Alberto Ferro Vernis a ongles
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (fr) * 1989-07-27 1991-01-28 Philippe Guerry Derives d'aminoalkoxybenzene substitues
FR2666962B1 (fr) 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására

Also Published As

Publication number Publication date
HU219480B (hu) 2001-04-28
NO922006L (no) 1992-11-24
DK0515312T3 (da) 1996-11-18
ZA923765B (en) 1993-11-22
FI109333B (fi) 2002-07-15
GB2256138B (en) 1995-01-11
ITRM920381A0 (it) 1992-05-22
IL101944A0 (en) 1992-12-30
RU2110257C1 (ru) 1998-05-10
NO300084B1 (no) 1997-04-07
FR2676647B1 (fr) 1995-05-12
HK1000242A1 (en) 1998-02-13
FR2676647A1 (fr) 1992-11-27
ATA105892A (de) 1995-06-15
GR3021551T3 (en) 1997-02-28
IE921670A1 (en) 1992-12-02
IL101944A (en) 1998-07-15
IT1254571B (it) 1995-09-25
LU88117A1 (fr) 1993-12-06
PH31205A (en) 1998-05-05
JP3527749B2 (ja) 2004-05-17
KR920021140A (ko) 1992-12-18
AU642090B2 (en) 1993-10-07
HU9201548D0 (en) 1992-07-28
CH683237A5 (de) 1994-02-15
EP0515312A2 (fr) 1992-11-25
HUT62467A (en) 1993-05-28
CS153292A3 (en) 1992-12-16
DE4215677B4 (de) 2008-01-17
KR100367150B1 (ko) 2003-03-03
IE66476B1 (en) 1995-12-27
CZ284232B6 (cs) 1998-09-16
AU1705892A (en) 1992-11-26
AT400518B (de) 1996-01-25
EP0515312B1 (fr) 1996-08-14
CY2070B1 (en) 1998-09-11
NZ242849A (en) 1993-09-27
GB9210974D0 (en) 1992-07-08
CA2069153C (fr) 2002-12-17
ITRM920381A1 (it) 1993-11-22
EP0515312A3 (en) 1993-04-14
US5866105A (en) 1999-02-02
JPH05148136A (ja) 1993-06-15
DE4215677A1 (de) 1992-11-26
NO922006D0 (no) 1992-05-21
FI922316A0 (fi) 1992-05-21
US6214360B1 (en) 2001-04-10
FI922316A (fi) 1992-11-24
CA2069153A1 (fr) 1992-11-24
ES2091441T3 (es) 1996-11-01
RO112081B1 (ro) 1997-05-30
US6319509B1 (en) 2001-11-20
GB2256138A (en) 1992-12-02
MX9202407A (es) 1992-11-01

Similar Documents

Publication Publication Date Title
SK281130B6 (sk) Topická farmaceutická formuácia
US7074392B1 (en) Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
EP1257248B1 (fr) Composition pharmaceutique
CA2402267C (fr) Combinaisons anti-infectieuses de principes actifs et leur utilisation dans le traitement topique de mycoses des ongles des orteils et des doigts
BG63589B1 (bg) Използване на глицерилтриацетат за лечение на онихомикози
US20060280703A1 (en) Antimycotic nail varnish
US8257688B2 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
SA92130074B1 (ar) تركيبة صيدليه محتوية تيربينافين Terbenafing كعامل ضد الفطر agentanti-mycostic

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20120521